Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 8,401–8,425 of 27,380 studies, newest first · page 337 of 1096.
October 2022 25
-
2022-10-09
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community-engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4
74/100 ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia : the journal of the Alzheimer's Association
Key finding: The Alzheimer's Disease Neuroimaging Initiative (ADNI) aims to validate biomarkers for Alzheimer's disease (AD) clinical trials.
Full summary, score breakdown and related studies → Original source
-
2022-10-08
Aluminum neurotoxicity and autophagy: a mechanistic view
41/100 ✓ Peer-reviewed Disease mechanisms Neurological research
Key finding: It is strongly believed that aluminum is one of the insalubrious agents because of its neurotoxicity effects and influences on amyloid β (Aβ) production and tau protein hyperphosphorylation following oxidative stress, as one of the initial events in neurotoxicity. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-08
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease
52/100 ✓ Peer-reviewed Genetics Communications biology
Key finding: Genome-wide and transcriptome-wide association studies have identified various genes and genetic variants in lipid metabolism that are associated with Alzheimer's disease.
Full summary, score breakdown and related studies → Original source
-
2022-10-07
Growth of Fee-for-Service Medicare Home-Based Medical Care Within Private Residences and Domiciliary Care Settings in the U.S., 2012-2019
38/100 ✓ Peer-reviewed Health systems and care delivery Journal of the American Medical Directors Association
Key finding: The median (interquartile range) state-level HBMC utilization rate per 1000 FFS population was 67.6 (34.1-151.3) visits overall, 17.3 (7.9-41.9) visits in private residences, and 47.7 (23.1-86.6) visits in domiciliary settings. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2022-10-06
Serum lipid traits and the risk of dementia: A cohort study of 254,575 women and 214,891 men in the UK Biobank
51/100 ✓ Peer-reviewed Long-term cohort studies EClinicalMedicine
Key finding: Serum lipid traits are associated with cardiovascular disease, but uncertainty remains regarding their associations with dementia. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-05
Diabetes and dementia: Clinical perspective, innovation, knowledge gaps
41/100 ✓ Peer-reviewed Risk factors Journal of diabetes and its complications
Key finding: It concluded, along with other studies, that diabetes as well as obesity and the metabolic syndrome more broadly, which are frequently comorbid, raise the risk of developing dementia. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2022-10-05
Biomarkers of neurodegeneration in neural autoantibody-associated psychiatric syndromes: A retrospective cohort study
34/100 ✓ Peer-reviewed Tau biomarkers Journal of translational autoimmunity
Key finding: Autoantibody-associated psychiatric syndromes are a novel disease entity that is not fully understood. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-03
Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers
41/100 ✓ Peer-reviewed Brain tissue and pathology Current neurology and neuroscience reports
Key finding: Limbic-predominant age-related TDP-43 encephalopathy (LATE) is a recently defined neurodegenerative disease characterized by amnestic phenotype and pathological inclusions of TAR DNA-binding protein 43 (TDP-43). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-03
Interaction between autophagy and the NLRP3 inflammasome in Alzheimer's and Parkinson's disease
41/100 ✓ Peer-reviewed Inflammation and the immune system Frontiers in aging neuroscience
Key finding: However, the related mechanism is not entirely clear. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-03
Long-term particulate matter 2.5 exposure and dementia: a systematic review and meta-analysis
70/100 ✓ Peer-reviewed Risk factors Public health
Key finding: In total, 20 articles were selected for review; 18 included results on the long-term effects of PM2.5 on dementia, 13 on AD, and eight on VaD. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-03
Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues
41/100 ✓ Peer-reviewed Drug development Frontiers in pharmacology
Key finding: Kinase inhibitors, for example, which were developed for various oncology indications, demonstrated significant neuroprotective effects in neurodegenerative diseases.
Full summary, score breakdown and related studies → Original source
-
2022-10-03
Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals
59/100 ✓ Peer-reviewed Tau biomarkers Neurology
Key finding: In this retrospective study, GAP-43 was measured in participants from the AD Neuroimaging Initiative (ADNI) cohort using an in-house ELISA method, and levels were compared between groups, both cross-sectionally and longitudinally. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-03
Effect of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic Stroke: A Randomized Clinical Trial
69/100 ✓ Peer-reviewed Treatments JAMA network open
Key finding: One-hundred and twenty participants, with a mean (range) of 1.2 (1-4) strokes, a mean (SD) of 66.5 (53.8) months since the most recent stroke, mean (SD) baseline age of 70 (8) years, mean (SD) baseline ADAS-Cog-Plus of 0.22 (0.81), and 74 (62%) male participants, were randomized to EX (34 participants), ENRICH (34 participants), or BAT (52 participants). +2 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-03
Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors
62/100 ✓ Peer-reviewed Biomarkers JAMA network open
Key finding: In this cross-sectional study of plasma biomarkers by race and genetic ancestry, the results indicated that plasma p-tau181, Aβ40, and NFL were lower in African American individuals based on self-reported race but not genetic ancestry. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-03
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study
74/100 ✓ Peer-reviewed Biomarkers JAMA neurology
Key finding: Data from 17 107 individuals (321 Asian, 635 Black, 829 Hispanic, and 15 322 White) with MCI or dementia and amyloid PET were analyzed between April 2020 and January 2022. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2022-10-02
Comparison of plasma and CSF biomarkers in predicting cognitive decline
55/100 ✓ Peer-reviewed Biomarkers Annals of clinical and translational neurology
Key finding: Both plasma and CSF measures of Aβ42/Aβ40 and NfL predicted cognitive decline. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10 month only
Association between depression, gender and Alzheimer's neuropathology in older adults without dementia
63/100 ✓ Peer-reviewed Risk factors International journal of geriatric psychiatry
Key finding: This study included 407 participants (96 Thal, 405 Braak, and 406 CERAD). +3 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10 month only
Blood based biomarkers for movement disorders
48/100 ✓ Peer-reviewed Biomarkers Acta neurologica Scandinavica
Key finding: NfL is also a prognostic biomarker, in that the level of baseline or cross-sectional plasma/serum NfL is associated with a worse prognosis in PD and PSP.
Full summary, score breakdown and related studies → Original source
-
2022-10-01
Effects of postoperative cognitive training on neurocognitive decline after heart surgery: a randomized clinical trial
74/100 ✓ Peer-reviewed Prevention trials European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Key finding: Since our cognitive training showed beneficial effects, it could be a promising method to prevent POCD.
Full summary, score breakdown and related studies → Original source
-
2022-10-01
The Blondes of Wisconsin
24/100 ✓ Peer-reviewed Risk factors Polish American Studies
Key finding: Still, there's something earnest and noble in his face” (p. 126). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-01
CSF Alzheimer Disease Biomarkers: Time-Varying Relationships With MCI Symptom Onset and Associations With Age, Sex, and ApoE4
64/100 ✓ Peer-reviewed Tau biomarkers Neurology
Key finding: This study aimed to examine whether baseline CSF measures of Alzheimer disease (AD)-related pathology are associated with the time to onset of mild cognitive impairment (MCI) and whether these associations differ by age, sex, Apolipoprotein E ( ApoE4 ) status, and proximal (≤7 years) vs distal (>7 years) time to symptom onset. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-01
TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways
58/100 ✓ Peer-reviewed TREM2 and immune genetics Cell
Key finding: Microglia that adhere to Aβ plaques acquire a transcriptional signature, "disease-associated microglia" (DAM), which largely emanates from the TREM2-DAP12 receptor complex that transmits intracellular signals through the protein tyrosine kinase SYK. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-01
Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment
66/100 ✓ Peer-reviewed Brain scans and imaging JAMA neurology
Key finding: Among 580 participants (PREVENT-AD, 128; HABS, 153; AIBL, 48; Knight ADRC, 251), mean (SD) age ranged from 67 (5) to 76 (6) years across cohorts, with between 55% (137/251) and 74% (95/128) female participants. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2022-10-01
Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial
76/100 ✓ Peer-reviewed Treatments JAMA neurology
Key finding: The primary study randomized 272 participants (mean [SD] age, 75.2 [5.5] years; 145 female participants [53.3%]). +2 more findings
Full summary, score breakdown and related studies → Original source
-
2022-10-01
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology
56/100 ✓ Peer-reviewed Biomarkers Brain : a journal of neurology
Key finding: The extent to which the pathophysiology of autosomal dominant Alzheimer's disease corresponds to the pathophysiology of 'sporadic' late onset Alzheimer's disease is unknown, thus limiting the extrapolation of study findings and clinical trial results in autosomal dominant Alzheimer's disease to late onset Alzheimer's disease. +2 more findings
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →